From the publishers of The New England Journal of Medicine

Save time and stay informed. Our physician-editors offer you clinical perspectives on key research and news.

  1. Home>
  2. Specialties>
  3. Psychiatry>
  4. Summary and Comment

MDMA May Be Neurotoxic to Dopamine Neurons

The authors of this Science article retracted its publication on September 12, 2003.

Ecstasy ([±]3,4-methylenedioxymethamphetamine; MDMA), a common drug of abuse in the U.S. and elsewhere, has been shown to be a serotonin neurotoxin in rodent and nonhuman primate studies. In this 3-part, nonhuman primate study, researchers examined the effects of MDMA at a dosage that mimicked recreational use.

MDMA (3 doses of 2 mg/kg at 3-hour intervals) was injected into 5 squirrel monkeys. One monkey developed an unsteady gait and was not given the third dose; another developed malignant hyperthermia and died soon after the last dose. Two weeks after MDMA exposure, researchers assessed markers of the integrity of brain serotonergic and dopaminergic neurons in the 3 remaining animals and in 3 saline-treated controls. In addition to exhibiting serotonin toxicity, the MDMA-exposed monkeys showed greater dopamine toxicity, with significant reductions in various markers of striatal dopaminergic axon terminals. Similar findings were reported 6 weeks after MDMA exposure in the monkey that received only 2 doses.

To determine whether these findings were species-specific, the researchers conducted similar studies in 5 baboons. One MDMA-exposed baboon died of malignant hyperthermia, and another received only 2 doses because of side effects. Although measures of norepinephrine and norepinephrine transporters were unaffected, a profound loss of striatal dopaminergic axonal markers was observed.

To study the risk for parkinsonism in 3 MDMA-exposed monkeys, the researchers reduced brain dopamine levels with alphamethyl-paratyrosine (AMPT) 1 week before and 1 week after MDMA exposure. After receiving MDMA, the monkeys were considerably more sensitive to the effects of AMPT-induced motor dysfunction.

Comment: These results suggest that recreational MDMA users may be at risk for Parkinson's disease and may sustain long-lasting destruction of brain dopamine neurons.

— Charles Nemeroff, MD, PhD

Published in Journal Watch Psychiatry November 21, 2002

Citation(s):

Ricaurte GA et al. Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy"). Science 2002 Sep 27; 297:2260-3.

Ricaurte GA et al. Retraction. Science 2003 Sep 12; 301:1479.

Holden C. Retraction: Paper on toxic party drug is pulled over vial mix-up. Science 2003 Sep 12; 301:1454.

Your Remark:

Reader Remarks are intended to encourage lively discussion of clinical topics with your peers in the medical community. Please consider this when composing your remark.

Fields marked with an * are required.

Name as you'd like it to appear:

Submitting a comment indicates you have read and agreed to the remark guidelines and declare:*

PRIVACY: We will not use your email address, submitted for a comment, for any other purpose nor sell, rent, or share your e-mail address with any third parties. Please see our Privacy Policy.

 

CLEAR erases anything you've added in any part of the form. CONTINUE allows you to check your entire post (and edit it if necessary) before submitting.

To ensure that your Reader Remark is not formatted as one long paragraph, precede new paragraphs with either a blank line or an indentation.

Search

Advanced

Article Tools

Reader Remarks

Sign-In

Forgot your password?

New to Journal Watch?

E-mail Alerts

Delivered to your inbox.
Tailored to your interests. Free.

Sign Up Now!

Journal Watch Newsletters

Available in 13 specialties with convenient delivery and 10 free online CME exams.

Subscribe Now!

Copyright © 2002. Massachusetts Medical Society. All rights reserved.